Navigation Links
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Date:12/23/2009

ely $380 million) and its market share was about 12%.

About Dyslipidemia and Hypercholesterolemia

Dyslipidemia refers to abnormal levels of fatty substances in the blood, or a disorder of the production or breakdown process of lipoprotein. Dyslipidemia may be marked by an elevation of total cholesterol, LDL-C, and triglyceride (TG) concentrations and a decrease in HDL-C in the blood. An elevated level of cholesterol in the blood is called hypercholesterolemia, commonly referred to as high cholesterol.

LDL-C lowering is well established as one of the strongest independent predictors of cardiovascular morbidity and mortality. Despite the availability of treatments in the U.S., there is still a need for better control of and treatment for dyslipidemia. According to the American Heart Association, approximately one out of every three American adults has an LDL cholesterol level of 130mg/dL or higher, which is a major risk factor for coronary heart disease (CHD) and stroke. In addition, less than half of patients who qualify for any kind of lipid-modifying treatment for CHD risk reduction are receiving it, and only about one-third of patients who are on treatment are achieving their LDL goals.

IMPORTANT SAFETY INFORMATION ABOUT LIVALO® (PITAVASTATIN) TABLETS

INDICATIONS AND USAGE

Drug therapy should be one component of multiple-risk-factor intervention in individuals who require modifications of their lipid profile. Lipid-altering agents should be used in addition to a diet restricted in saturated fat and cholesterol only when the response to diet and other nonpharmacological measures has been inadequate.

LIVALO is a HMG-CoA reductase inhibitor indicated as an adjunctive therapy to diet to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase HDL-C in adult patients with
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014" ... conventional methods developed to prevent and eradicate the prevalence ... These methods are confined to low specificity, safety and ... to look for a better solution. It has been ...
(Date:8/29/2014)... Does your doctor know what you,re smoking?  Chances ... marijuana to the over 112,000 currently registered patients under ... the other roughly 20,300+ active physicians listed with the Colorado ... – even though a poll in February 2014 showed 51% ... tried it. "With marijuana legalization underway, every ...
(Date:8/29/2014)... 2014   Vittamed Corporation , a neurodiagnostics medical device ... that T. (Teo) Forcht Dagi , MD, DmedSc, MPH, ... Directors. " Teo Forcht Dagi is ... innovation and venture capital," said Remis Bistras , President ... his clinical, strategic, and entrepreneurial expertise to our Board." ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2
... Data presented today,at the Annual Congress of ... oral Factor Xa inhibitor DU-176b reduced the incidence,of ... elective unilateral hip replacement surgery. There was a,statistically ... the,observed bleeding rates were low across the groups. ...
... Bypass Surgery for Safety and ... Condition, WASHINGTON, Sept. 1 Patients with both ... will find good news in,new findings announced today from ... Interventions (SCAI). The one-year findings,of the new study indicate ...
Cached Medicine Technology:Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b 2SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI 2SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI 3
(Date:9/2/2014)... 2014: Digoxin may increase the risk of death in ... to results from the ROCKET AF trial presented at ... interventional cardiology and catheterisation labs at Duke University Health ... that caution may be needed when using digoxin in ... confirm the observations. , Dr Patel said: "In this ...
(Date:9/2/2014)... September 2014: The fact that mechanical heart valves increase ... data from the ROPAC registry presented for the first ... by Professor Jolien W. Roos-Hesselink, co-chair with Professor Roger ... that 1.4% of pregnant women with a mechanical heart ... , The Registry Of Pregnancy And Cardiac disease (ROPAC) ...
(Date:9/2/2014)... Aeroflow Healthcare, an industry leader and home ... opening of its new office to be located in ... Parkway, Suite D, Greer, SC 29651. This new location ... more convenient location in the Greenville area. , “This ... physicians, hospitals and patients we serve, to ensure that ...
(Date:9/2/2014)... Attorney Robert M. Higgins has been named by ... Medical Malpractice Law - Plaintiffs. Higgins is a ... selected for inclusion in The Best Lawyers in America each ... and designated metropolitan area is honored as the “Lawyer of ... the peer-review assessments. , The Best Lawyers ...
(Date:9/2/2014)... Productive Dentist Academy, a dental marketing ... been named to Inc. Magazine’s 5000 list for fastest-growing ... year in a row it has obtained this distinction. ... percent growth rate and increased revenues from $1.9 million ... number of employees from eight to 25. All of ...
Breaking Medicine News(10 mins):Health News:ROCKET AF trial suggests that digoxin increases risk of death in AF patients 2Health News:Mechanical heart valves increase pregnancy risk 2Health News:Mechanical heart valves increase pregnancy risk 3Health News:Aeroflow Healthcare Opens Office In Greer, SC To Service Greenville & Spartanburg Patients 2Health News:Robert Higgins Named 2015 Best Lawyers® "Lawyer of the Year" in Boston 2Health News:Dental Management Company Named to Fastest-Growing List Again 2Health News:Dental Management Company Named to Fastest-Growing List Again 3
... 20 Purdue Pharma L.P. and Mundipharma International Corporation ... global strategic alliance with Infinity Pharmaceuticals, Inc. to advance ... early clinical programs in the areas of oncology and ... The alliance will focus on supporting Infinity,s ...
... Healthplace America is pleased to,introduce Surgery Benefit Management ... the Healthplace Benefit(TM), is the first and only,comprehensive ... employer health plans while enhancing employee benefits with ... Surgery accounts for $700 billion ...
... in the field of,implant dentistry about proper use of ... the shorter, less costly procedure while others advocate a,more ... to the American Academy of Implant Dentistry (AAID), http://www.aaid.com ... also have been raised about whether general dentists who ...
... (Terry) Fontham, MPH, DrPH, Dean of the LSU Health Sciences Center ... elected national President of the American Cancer Society when she is ... on November 20, 2008 in New York City. She will ... as president in the organization,s 96-year history., ...
... Lets Terminally Ill Vietnam Veteran Regain Mobility and Independence , ... Tough odds have never stopped Anthony Radonski. He has survived the ... lymphoma. Immobility, though, has tested the 60-year-old war hero,s spirit like ... free power wheelchair to him. , ...
... Allscripts,today announced that Kindred Healthcare, Inc., the nation,s ... Referral Management,Plus to help manage and coordinate patient ... and 228 nursing and rehabilitation,centers across the nation. ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) , ...
Cached Medicine News:Health News:Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain 2Health News:Healthplace America Delivers the First and Only Surgery Benefit Management Solution Through the Healthplace Benefit(TM) 2Health News:Healthplace America Delivers the First and Only Surgery Benefit Management Solution Through the Healthplace Benefit(TM) 3Health News:Use of Mini Dental Implants on the Rise but Questions Linger 2Health News:Use of Mini Dental Implants on the Rise but Questions Linger 3Health News:LSUHSC's Fontham makes history 2Health News:LSUHSC's Fontham makes history 3Health News:The SCOOTER Store Donates Power Wheelchair to California War Hero, a Purple Heart Recipient 2Health News:The SCOOTER Store Donates Power Wheelchair to California War Hero, a Purple Heart Recipient 3Health News:Kindred Healthcare, Nation's Largest Post-Acute Healthcare Provider, Selects Allscripts Referral Management 2Health News:Kindred Healthcare, Nation's Largest Post-Acute Healthcare Provider, Selects Allscripts Referral Management 3Health News:Kindred Healthcare, Nation's Largest Post-Acute Healthcare Provider, Selects Allscripts Referral Management 4Health News:Kindred Healthcare, Nation's Largest Post-Acute Healthcare Provider, Selects Allscripts Referral Management 5
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
The perfect tool to prepare for in-service or licensing exams, for recertification, or for use as a clinical refresher....
... Sun Med TruFlow™ Oxygen flowmeter with a ... warranty covering calibration and manufacturing defects. A ... meet most needs. Also available with all ... power take-off and double unit configurations. Our ...
... flowmeter with a Lexan®inner calibrated flow tube ... manufacturing defects. A wide range of configurations ... available with all popular inlet connections, a ... unit configurations. Our extra large knob coupled ...
Medicine Products: